CAMERA2 – combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial
出版年份 2016 全文链接
标题
CAMERA2 – combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial
作者
关键词
Staphylococcus aureus, Methicillin-resistant, MRSA, Vancomycin, Combination, Randomised controlled trial, Daptomycin, Flucloxacillin, Cloxacillin, Cefazolin, Nafcillin
出版物
Trials
Volume 17, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-03-31
DOI
10.1186/s13063-016-1295-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- ReducedIn VitroActivity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from Australia
- (2015) I. J. Abbott et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial
- (2015) Joshua S. Davis et al. CLINICAL INFECTIOUS DISEASES
- Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
- (2015) Steven Y. C. Tong et al. CLINICAL MICROBIOLOGY REVIEWS
- Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections
- (2015) S. Hal et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Evaluation of Ceftaroline, Vancomycin, Daptomycin, or Ceftaroline plus Daptomycin against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in anIn VitroPharmacokinetic/Pharmacodynamic Model of Simulated Endocardial Vegetations
- (2014) Brian J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline
- (2014) George Sakoulas et al. CLINICAL THERAPEUTICS
- Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes
- (2014) K. E. Barber et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Comparison of the Incidence of Vancomycin-Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin-Tazobactam
- (2014) Lindsey D. Burgess et al. PHARMACOTHERAPY
- Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or Cefepime
- (2014) Diane M. Gomes et al. PHARMACOTHERAPY
- Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA
- (2013) B. J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Ceftaroline Activity against Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate Methicillin-Resistant S. aureus Strains in anIn VitroPharmacokinetic/Pharmacodynamic Model: Exploring the “Seesaw Effect”
- (2013) Brian J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Vancomycin in Combination with Piperacillin-Tazobactam or Oxacillin against Clinical Methicillin-Resistant Staphylococcus aureus Isolates and Vancomycin-Intermediate S. aureus IsolatesIn Vitro
- (2013) Thomas J. Dilworth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?
- (2013) S. J. van Hal et al. CLINICAL INFECTIOUS DISEASES
- Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the “seesaw effect”: Taking advantage of the back door left open?
- (2013) Jessica K. Ortwine et al. DRUG RESISTANCE UPDATES
- The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA
- (2013) Benjamin P. Howden et al. INFECTION GENETICS AND EVOLUTION
- Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
- (2013) George Sakoulas et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Synergistic Activity of Ceftobiprole and Vancomycin in a Rat Model of Infective Endocarditis Caused by Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus
- (2012) Jeffrey Fernandez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Daptomycin-Cloxacillin Combination in Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus
- (2012) C. Garrigós et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial Activity
- (2012) Warren E. Rose et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
- (2012) Brian J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
- (2012) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus
- (2012) S. N. Leonard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synergy between Vancomycin and Nafcillin against Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model
- (2012) Steven N. Leonard PLoS One
- Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial
- (2012) Guy Thwaites et al. Trials
- In VitroPharmacodynamics of Vancomycin and Cefazolin Alone and in Combination against Methicillin-Resistant Staphylococcus aureus
- (2011) Mao Hagihara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
- (2011) Natasha E. Holmes et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluation of the synergistic potential of vancomycin combined with other antimicrobial agents against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus spp strains
- (2011) Lívia Viganor da Silva et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides
- (2010) S. Ribes et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Lack of Bactericidal Antagonism or Synergism In Vitro between Oxacillin and Vancomycin against Methicillin-Susceptible Strains of Staphylococcus aureus
- (2009) C. Joukhadar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin in Combination with Other Antibiotics for the Treatment of Serious Methicillin‐ResistantStaphylococcus aureusInfections
- (2009) Stan Deresinski CLINICAL INFECTIOUS DISEASES
- Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?
- (2009) H. M. Nguyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Staphylococcus aureus Bacteraemia in a Tropical Setting: Patient Outcome and Impact of Antibiotic Resistance
- (2009) Emma K. Nickerson et al. PLoS One
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
- (2008) M. Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started